Levofloxacin Injection, Solution
Product Images NDC 25021-132

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 25021-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Lev0b 0000 01)

Figure 1 (Lev0b 0000 01)
Chemical structure of levofloxacin monohydrate showing the molecular arrangement including fluorine, ketone, carboxyl, and methyl groups along with the molecular hydrate form indicated as 1/2 H2O.*
FDA Label Image

Figure 2 (Lev0b 0000 02)

Figure 2 (Lev0b 0000 02)
A line graph showing plasma concentration (µg/mL) over time (hours) for 750 mg Levofloxacin administered orally as a tablet and intravenously as a 90-minute infusion. The graph compares pharmacokinetic profiles, with higher initial plasma concentration for the IV infusion that decreases over time, both methods showing a decline in drug levels up to 36 hours.*
FDA Label Image

Figure 3 (Lev0b 0000 03)

Figure 3 (Lev0b 0000 03)
A pharmacokinetic graph showing plasma concentration (µg/mL) of levofloxacin over time (hours). The chart compares plasma levels after 500 mg tablet oral administration and 500 mg intravenous administration with concentration decreasing over 36 hours.*
FDA Label Image

Package Label – Principal Display Panel – Bag Label (Lev0b 0007 04)

Package Label – Principal Display Panel – Bag Label (Lev0b 0007 04)
Levofloxacin Injection 250 mg (5 mg/mL) in 50 mL 5% Dextrose sterile solution labeled for intravenous use. The label states single-use container instructions and advises immediate use after removing the overwrap. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in Switzerland, with a visible barcode and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.